{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:32:24Z","timestamp":1792099944359,"version":"4.4.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Australasian Hair and Wool Research Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Alopecia areata (AA) has an impact on health-related quality of life (HRQoL). The Women\u2019s Androgenetic Alopecia Quality of Life (WAA-QoL)\u00a0questionnaire is a reliable, validated HRQoL measure in women with androgenetic alopecia (AGA). There is no equivalent measure for female patients with AA. Data were collected as part of the\u00a0Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS) Australia. The WAA-QoL, Dermatology Life Quality Index (DLQI)\u00a0and Skindex-16 for AA, as well as the\u00a0Severity of Alopecia Tool score, were extracted from GRASS for adult female patients. Cronbach\u2019s alpha and factor analysis were employed to determine the internal consistency of the measure, and nonparametric correlation testing assessed the validity of the questionnaire. Overall, 137 individuals completed the questionnaires. There was excellent internal consistency of the WAA-QoL among women with AA (Cronbach\u2019s \u03b1 = 0.98). A moderate and high positive correlation was found between the WAA-QoL and the DLQI and the Skindex-16 for AA, respectively. The WAA-QoL is a reliable and valid assessment of HRQoL among women with AA.<\/jats:p>","DOI":"10.1093\/ced\/llad066","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T19:40:26Z","timestamp":1676922026000},"page":"681-684","source":"Crossref","is-referenced-by-count":5,"title":["Reliability and validity of a measure to assess the health-related quality of life of women with alopecia areata"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-4474","authenticated-orcid":false,"given":"Huw","family":"Rees","sequence":"first","affiliation":[{"name":"Sinclair Dermatology , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Wall","sequence":"additional","affiliation":[{"name":"National and International Skin Registry Solutions (NISR) , Dublin , Ireland"},{"name":"Hair Restoration Blackrock , Dublin , Ireland"},{"name":"Charles Institute of Dermatology, School of Medicine, University College Dublin , Dublin , Ireland"},{"name":"Mater Misericordiae University Hospital , Dublin , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laita","family":"Bokhari","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Asfour","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology , Melbourne, VIC , Australia"},{"name":"Department of Medicine, University of Melbourne , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"2023100918451171500_llad066-B1","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.jid.2022.02.019","article-title":"Predictors of QOL in patients with alopecia areata","volume":"142","author":"Senna","year":"2022","journal-title":"J Invest Dermatol"},{"key":"2023100918451171500_llad066-B2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/bjd.20628","article-title":"The epidemiology of alopecia areata: a population-based cohort study in UK primary care","volume":"186","author":"Harries","year":"2022","journal-title":"Br J Dermatol"},{"key":"2023100918451171500_llad066-B3","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jisp.2020.05.007","article-title":"Burden of illness in alopecia areata: a cross-sectional online survey study","volume":"20","author":"Mesinkovska","year":"2020","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2023100918451171500_llad066-B4","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/jidsymp.2013.18","article-title":"Health-related quality of life (HRQoL) in alopecia areata patients \u2013 a secondary analysis of the National Alopecia Areata Registry Data","volume":"16","author":"Shi","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2023100918451171500_llad066-B5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2230.2000.00726.x","article-title":"Development of a health-related quality of life questionnaire for women with androgenetic alopecia","volume":"25","author":"Dolte","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"2023100918451171500_llad066-B6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br J Dermatol"},{"key":"2023100918451171500_llad066-B7","first-page":"997","article-title":"The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"key":"2023100918451171500_llad066-B8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/120347540100500202","article-title":"Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases","volume":"5","author":"Chren","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"2023100918451171500_llad066-B9","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two Phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"key":"2023100918451171500_llad066-B10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaad.2016.09.007","article-title":"Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients","volume":"76","author":"Liu","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad066\/49529710\/llad066.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/6\/681\/51961877\/llad066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/6\/681\/51961877\/llad066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T18:50:03Z","timestamp":1696877403000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/6\/681\/7048912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":10,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,2,20]]},"published-print":{"date-parts":[[2023,6,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad066","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,2,20]]}}}